| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.93e-10 | 14 | 52 | 5 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 3.19e-09 | 23 | 52 | 5 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 1.11e-08 | 29 | 52 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.11e-08 | 29 | 52 | 5 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.58e-08 | 34 | 52 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 6.63e-08 | 210 | 52 | 8 | GO:0019903 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 1.13e-07 | 149 | 52 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.72e-07 | 49 | 52 | 5 | GO:0051861 | |
| GeneOntologyMolecularFunction | phosphatase binding | 3.82e-07 | 264 | 52 | 8 | GO:0019902 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.05e-06 | 70 | 52 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.29e-06 | 73 | 52 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 3.66e-06 | 90 | 52 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 1.58e-05 | 207 | 52 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 1.62e-05 | 208 | 52 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | protein kinase binding | 7.21e-05 | 873 | 52 | 10 | GO:0019901 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 8.61e-05 | 173 | 52 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.10e-04 | 293 | 52 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.55e-04 | 196 | 52 | 5 | GO:0005319 | |
| GeneOntologyMolecularFunction | kinase binding | 1.70e-04 | 969 | 52 | 10 | GO:0019900 | |
| GeneOntologyMolecularFunction | calmodulin binding | 3.25e-04 | 230 | 52 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.36e-03 | 316 | 52 | 5 | GO:0035091 | |
| GeneOntologyMolecularFunction | actin binding | 1.48e-03 | 479 | 52 | 6 | GO:0003779 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 1.52e-03 | 324 | 52 | 5 | GO:0005126 | |
| GeneOntologyMolecularFunction | phospholipid binding | 2.90e-03 | 548 | 52 | 6 | GO:0005543 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 3.70e-03 | 398 | 52 | 5 | GO:0046982 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 3.75e-03 | 35 | 52 | 2 | GO:0008376 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 4.97e-03 | 815 | 52 | 7 | GO:0042803 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.00e-10 | 14 | 54 | 5 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 2.99e-10 | 15 | 54 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 2.99e-10 | 15 | 54 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 2.99e-10 | 15 | 54 | 5 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 2.99e-10 | 15 | 54 | 5 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 4.35e-10 | 16 | 54 | 5 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 6.15e-10 | 17 | 54 | 5 | GO:0070342 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 6.15e-10 | 17 | 54 | 5 | GO:0038158 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 6.15e-10 | 17 | 54 | 5 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 8.49e-10 | 18 | 54 | 5 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.53e-09 | 20 | 54 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 2.01e-09 | 21 | 54 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 2.01e-09 | 21 | 54 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.01e-09 | 21 | 54 | 5 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.59e-09 | 22 | 54 | 5 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.30e-09 | 23 | 54 | 5 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.30e-09 | 23 | 54 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 4.16e-09 | 24 | 54 | 5 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 4.16e-09 | 24 | 54 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 4.16e-09 | 24 | 54 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 5.19e-09 | 25 | 54 | 5 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 5.19e-09 | 25 | 54 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 7.86e-09 | 27 | 54 | 5 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 9.55e-09 | 28 | 54 | 5 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.15e-08 | 29 | 54 | 5 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.64e-08 | 31 | 54 | 5 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 1.94e-08 | 32 | 54 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.94e-08 | 32 | 54 | 5 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.94e-08 | 32 | 54 | 5 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.28e-08 | 33 | 54 | 5 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.28e-08 | 33 | 54 | 5 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.67e-08 | 34 | 54 | 5 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.67e-08 | 34 | 54 | 5 | GO:0046851 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 2.86e-08 | 187 | 54 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 3.11e-08 | 35 | 54 | 5 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 4.78e-08 | 38 | 54 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 5.47e-08 | 39 | 54 | 5 | GO:0045717 | |
| GeneOntologyBiologicalProcess | multi-organism reproductive process | 5.80e-08 | 290 | 54 | 9 | GO:0044703 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 6.24e-08 | 40 | 54 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | multi-multicellular organism process | 6.52e-08 | 294 | 54 | 9 | GO:0044706 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 7.10e-08 | 41 | 54 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 8.04e-08 | 42 | 54 | 5 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 9.68e-08 | 86 | 54 | 6 | GO:0042058 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.15e-07 | 45 | 54 | 5 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.29e-07 | 46 | 54 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.29e-07 | 46 | 54 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.44e-07 | 47 | 54 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.44e-07 | 47 | 54 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.44e-07 | 47 | 54 | 5 | GO:0034104 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 1.55e-07 | 93 | 54 | 6 | GO:1901184 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.78e-07 | 49 | 54 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.78e-07 | 49 | 54 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.97e-07 | 50 | 54 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 2.41e-07 | 52 | 54 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | female pregnancy | 2.60e-07 | 249 | 54 | 8 | GO:0007565 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 2.65e-07 | 53 | 54 | 5 | GO:0034110 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 2.85e-07 | 252 | 54 | 8 | GO:0022408 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 3.51e-07 | 56 | 54 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 3.57e-07 | 107 | 54 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 4.58e-07 | 59 | 54 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | receptor internalization | 4.63e-07 | 182 | 54 | 7 | GO:0031623 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 4.98e-07 | 60 | 54 | 5 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 4.98e-07 | 60 | 54 | 5 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 5.19e-07 | 114 | 54 | 6 | GO:0045824 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 5.42e-07 | 61 | 54 | 5 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 8.05e-07 | 66 | 54 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 8.53e-07 | 124 | 54 | 6 | GO:0050672 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 8.69e-07 | 67 | 54 | 5 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 9.37e-07 | 126 | 54 | 6 | GO:0032945 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 1.01e-06 | 69 | 54 | 5 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 1.08e-06 | 70 | 54 | 5 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 1.08e-06 | 70 | 54 | 5 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 1.16e-06 | 71 | 54 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 1.16e-06 | 71 | 54 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 1.25e-06 | 72 | 54 | 5 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 1.25e-06 | 72 | 54 | 5 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 1.34e-06 | 73 | 54 | 5 | GO:0042304 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid metabolic process | 1.34e-06 | 134 | 54 | 6 | GO:0019217 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 1.34e-06 | 134 | 54 | 6 | GO:0070664 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.46e-06 | 313 | 54 | 8 | GO:0098742 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 1.63e-06 | 76 | 54 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | epidermal growth factor receptor signaling pathway | 1.66e-06 | 139 | 54 | 6 | GO:0007173 | |
| GeneOntologyBiologicalProcess | energy homeostasis | 2.04e-06 | 144 | 54 | 6 | GO:0097009 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 2.11e-06 | 80 | 54 | 5 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 2.11e-06 | 80 | 54 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 2.53e-06 | 83 | 54 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 2.69e-06 | 151 | 54 | 6 | GO:0002832 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 2.85e-06 | 85 | 54 | 5 | GO:1903670 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 2.85e-06 | 85 | 54 | 5 | GO:0002762 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response | 2.86e-06 | 239 | 54 | 7 | GO:0050777 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 3.19e-06 | 87 | 54 | 5 | GO:0001974 | |
| GeneOntologyBiologicalProcess | ERBB signaling pathway | 3.77e-06 | 160 | 54 | 6 | GO:0038127 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 3.99e-06 | 91 | 54 | 5 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 3.99e-06 | 91 | 54 | 5 | GO:0030193 | |
| GeneOntologyBiologicalProcess | feeding behavior | 4.05e-06 | 162 | 54 | 6 | GO:0007631 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 4.44e-06 | 93 | 54 | 5 | GO:1900046 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 4.93e-06 | 95 | 54 | 5 | GO:0070527 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 5.19e-06 | 96 | 54 | 5 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 5.19e-06 | 96 | 54 | 5 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 5.52e-06 | 171 | 54 | 6 | GO:0050868 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 3.69e-10 | 16 | 53 | 5 | GO:0070021 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 2.84e-09 | 90 | 53 | 7 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.75e-07 | 98 | 53 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 2.80e-06 | 157 | 53 | 6 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 4.43e-06 | 170 | 53 | 6 | GO:1902911 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.55e-05 | 320 | 53 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | adherens junction | 1.56e-05 | 212 | 53 | 6 | GO:0005912 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.59e-05 | 591 | 53 | 9 | GO:0005911 | |
| GeneOntologyCellularComponent | basal plasma membrane | 2.97e-05 | 354 | 53 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 4.51e-05 | 378 | 53 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | T cell receptor complex | 5.75e-05 | 163 | 53 | 5 | GO:0042101 | |
| GeneOntologyCellularComponent | apical part of cell | 1.14e-04 | 592 | 53 | 8 | GO:0045177 | |
| GeneOntologyCellularComponent | anchoring junction | 1.47e-04 | 976 | 53 | 10 | GO:0070161 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 1.97e-04 | 335 | 53 | 6 | GO:0061695 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 2.50e-04 | 350 | 53 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | cell projection membrane | 7.51e-04 | 431 | 53 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 9.81e-04 | 817 | 53 | 8 | GO:0098978 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.41e-03 | 487 | 53 | 6 | GO:0016324 | |
| GeneOntologyCellularComponent | side of membrane | 1.52e-03 | 875 | 53 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | cell surface | 1.75e-03 | 1111 | 53 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.94e-03 | 519 | 53 | 6 | GO:0009897 | |
| GeneOntologyCellularComponent | receptor complex | 3.41e-03 | 581 | 53 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 3.51e-03 | 785 | 53 | 7 | GO:0098797 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.30e-09 | 17 | 43 | 5 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 4.25e-09 | 21 | 43 | 5 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 8.82e-09 | 24 | 43 | 5 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 1.66e-08 | 27 | 43 | 5 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 2.02e-08 | 28 | 43 | 5 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 3.47e-08 | 31 | 43 | 5 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 3.47e-08 | 31 | 43 | 5 | MP:0008964 | |
| MousePheno | obese | 4.74e-08 | 113 | 43 | 7 | MP:0001261 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 6.57e-08 | 35 | 43 | 5 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 7.61e-08 | 36 | 43 | 5 | MP:0031412 | |
| MousePheno | increased total tissue mass | 1.13e-07 | 364 | 43 | 10 | MP:0012323 | |
| MousePheno | increased body weight | 1.13e-07 | 364 | 43 | 10 | MP:0001260 | |
| MousePheno | decreased muscle cell glucose uptake | 1.15e-07 | 39 | 43 | 5 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 2.15e-07 | 44 | 43 | 5 | MP:0031023 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 3.02e-07 | 47 | 43 | 5 | MP:0031617 | |
| MousePheno | increased body size | 3.33e-07 | 409 | 43 | 10 | MP:0001264 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 3.74e-07 | 49 | 43 | 5 | MP:0020948 | |
| MousePheno | decreased cellular glucose uptake | 5.57e-07 | 53 | 43 | 5 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 6.13e-07 | 54 | 43 | 5 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 1.04e-06 | 60 | 43 | 5 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 1.13e-06 | 61 | 43 | 5 | MP:0010951 | |
| MousePheno | increased insulin secretion | 1.44e-06 | 64 | 43 | 5 | MP:0003058 | |
| MousePheno | decreased energy expenditure | 1.58e-06 | 119 | 43 | 6 | MP:0004890 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.82e-06 | 67 | 43 | 5 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 1.82e-06 | 67 | 43 | 5 | MP:0008962 | |
| MousePheno | abnormal vascular wound healing | 2.79e-06 | 73 | 43 | 5 | MP:0004883 | |
| MousePheno | decreased oxygen consumption | 4.13e-06 | 79 | 43 | 5 | MP:0005290 | |
| MousePheno | polyphagia | 4.39e-06 | 80 | 43 | 5 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection | 4.96e-06 | 82 | 43 | 5 | MP:0020914 | |
| MousePheno | abnormal endocrine gland physiology | 1.25e-05 | 363 | 43 | 8 | MP:0013561 | |
| MousePheno | abnormal cellular glucose uptake | 1.45e-05 | 102 | 43 | 5 | MP:0003925 | |
| MousePheno | decreased respiratory quotient | 2.09e-05 | 110 | 43 | 5 | MP:0010379 | |
| MousePheno | increased food intake | 2.27e-05 | 189 | 43 | 6 | MP:0011939 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 3.18e-05 | 120 | 43 | 5 | MP:0009786 | |
| MousePheno | increased total body fat amount | 3.83e-05 | 424 | 43 | 8 | MP:0010024 | |
| MousePheno | increased circulating leptin level | 3.87e-05 | 125 | 43 | 5 | MP:0005669 | |
| MousePheno | decreased susceptibility to viral infection | 3.87e-05 | 125 | 43 | 5 | MP:0002410 | |
| MousePheno | increased incidence of tumors by chemical induction | 6.88e-05 | 141 | 43 | 5 | MP:0004499 | |
| MousePheno | abnormal glycogen homeostasis | 7.60e-05 | 144 | 43 | 5 | MP:0005438 | |
| MousePheno | abnormal colon morphology | 9.82e-05 | 152 | 43 | 5 | MP:0000495 | |
| MousePheno | decreased susceptibility to infection | 1.20e-04 | 255 | 43 | 6 | MP:0002409 | |
| MousePheno | abnormal abdominal fat pad morphology | 1.39e-04 | 262 | 43 | 6 | MP:0000010 | |
| MousePheno | abnormal insulin secretion | 1.71e-04 | 171 | 43 | 5 | MP:0003564 | |
| MousePheno | increased incidence of induced tumors | 1.80e-04 | 173 | 43 | 5 | MP:0002021 | |
| MousePheno | abnormal blastocoele morphology | 1.80e-04 | 36 | 43 | 3 | MP:0004963 | |
| MousePheno | abnormal endocrine pancreas secretion | 1.95e-04 | 176 | 43 | 5 | MP:0014195 | |
| MousePheno | abnormal respiratory quotient | 2.06e-04 | 178 | 43 | 5 | MP:0004129 | |
| MousePheno | abnormal pancreas secretion | 2.34e-04 | 183 | 43 | 5 | MP:0002694 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 2.52e-04 | 186 | 43 | 5 | MP:0020912 | |
| MousePheno | abnormal wound healing | 2.99e-04 | 193 | 43 | 5 | MP:0005023 | |
| MousePheno | abnormal oxygen consumption | 3.14e-04 | 195 | 43 | 5 | MP:0005288 | |
| MousePheno | abnormal pancreatic beta cell physiology | 3.22e-04 | 196 | 43 | 5 | MP:0003562 | |
| MousePheno | insulin resistance | 3.29e-04 | 197 | 43 | 5 | MP:0005331 | |
| MousePheno | abnormal energy expenditure | 3.64e-04 | 313 | 43 | 6 | MP:0005450 | |
| MousePheno | abnormal endocrine pancreas physiology | 3.69e-04 | 202 | 43 | 5 | MP:0010147 | |
| MousePheno | abnormal fat pad morphology | 3.71e-04 | 314 | 43 | 6 | MP:0005334 | |
| MousePheno | abnormal lean body mass | 3.78e-04 | 749 | 43 | 9 | MP:0003959 | |
| MousePheno | abnormal muscle morphology | 3.92e-04 | 1106 | 43 | 11 | MP:0002108 | |
| MousePheno | abnormal energy homeostasis | 4.24e-04 | 322 | 43 | 6 | MP:0005448 | |
| MousePheno | abnormal food intake | 6.01e-04 | 481 | 43 | 7 | MP:0005449 | |
| MousePheno | increased triglyceride level | 6.98e-04 | 354 | 43 | 6 | MP:0005317 | |
| MousePheno | increased lean body mass | 6.98e-04 | 354 | 43 | 6 | MP:0003960 | |
| MousePheno | abnormal circulating leptin level | 7.50e-04 | 236 | 43 | 5 | MP:0005667 | |
| MousePheno | abnormal skeletal muscle morphology | 8.31e-04 | 508 | 43 | 7 | MP:0000759 | |
| MousePheno | abnormal susceptibility to infection | 8.90e-04 | 672 | 43 | 8 | MP:0001793 | |
| MousePheno | abnormal gland physiology | 1.07e-03 | 691 | 43 | 8 | MP:0002164 | |
| MousePheno | abnormal response to infection | 1.32e-03 | 714 | 43 | 8 | MP:0005025 | |
| MousePheno | abnormal incidence of induced tumors | 1.35e-03 | 269 | 43 | 5 | MP:0013151 | |
| MousePheno | abnormal response to antigen | 1.46e-03 | 726 | 43 | 8 | MP:0020000 | |
| MousePheno | decreased circulating triglyceride level | 1.48e-03 | 275 | 43 | 5 | MP:0002644 | |
| MousePheno | abnormal large intestine morphology | 1.51e-03 | 276 | 43 | 5 | MP:0000489 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 1.58e-03 | 279 | 43 | 5 | MP:0009785 | |
| MousePheno | abnormal susceptibility to viral infection | 1.58e-03 | 279 | 43 | 5 | MP:0020185 | |
| MousePheno | increased circulating insulin level | 1.68e-03 | 283 | 43 | 5 | MP:0002079 | |
| MousePheno | abnormal chondrocyte proliferation | 1.70e-03 | 20 | 43 | 2 | MP:0014099 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 1.76e-03 | 286 | 43 | 5 | MP:0008873 | |
| MousePheno | abnormal pancreas physiology | 1.93e-03 | 292 | 43 | 5 | MP:0002693 | |
| MousePheno | abnormal lung size | 1.96e-03 | 174 | 43 | 4 | MP:0004881 | |
| MousePheno | decreased CNS synapse formation | 2.05e-03 | 22 | 43 | 2 | MP:0004998 | |
| MousePheno | increased brain size | 2.25e-03 | 85 | 43 | 3 | MP:0005238 | |
| MousePheno | abnormal eating behavior | 2.26e-03 | 604 | 43 | 7 | MP:0001431 | |
| MousePheno | abnormal response to injury | 2.32e-03 | 607 | 43 | 7 | MP:0005164 | |
| Domain | Ig_2 | 5.74e-08 | 73 | 53 | 6 | PF13895 | |
| Domain | ig | 1.05e-06 | 190 | 53 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.05e-06 | 190 | 53 | 7 | IPR013151 | |
| Domain | IGc2 | 4.30e-06 | 235 | 53 | 7 | SM00408 | |
| Domain | Ig_sub2 | 4.30e-06 | 235 | 53 | 7 | IPR003598 | |
| Domain | V-set | 1.32e-05 | 184 | 53 | 6 | PF07686 | |
| Domain | Ig_V-set | 2.05e-05 | 199 | 53 | 6 | IPR013106 | |
| Domain | IG | 2.27e-05 | 421 | 53 | 8 | SM00409 | |
| Domain | Ig_sub | 2.27e-05 | 421 | 53 | 8 | IPR003599 | |
| Domain | IG_LIKE | 6.75e-05 | 491 | 53 | 8 | PS50835 | |
| Domain | KIND_dom | 7.86e-05 | 5 | 53 | 2 | IPR011019 | |
| Domain | KIND | 7.86e-05 | 5 | 53 | 2 | SM00750 | |
| Domain | KIND | 7.86e-05 | 5 | 53 | 2 | PS51377 | |
| Domain | Ig-like_dom | 7.99e-05 | 503 | 53 | 8 | IPR007110 | |
| Domain | - | 5.22e-04 | 663 | 53 | 8 | 2.60.40.10 | |
| Domain | Ig-like_fold | 7.88e-04 | 706 | 53 | 8 | IPR013783 | |
| Domain | CARD | 2.85e-03 | 28 | 53 | 2 | PF00619 | |
| Domain | Glycos_transf_2 | 3.27e-03 | 30 | 53 | 2 | PF00535 | |
| Domain | Glyco_trans_2-like | 3.27e-03 | 30 | 53 | 2 | IPR001173 | |
| Domain | UBA | 3.27e-03 | 30 | 53 | 2 | SM00165 | |
| Domain | CARD | 3.49e-03 | 31 | 53 | 2 | IPR001315 | |
| Domain | TGF-beta-rel | 3.71e-03 | 32 | 53 | 2 | IPR015615 | |
| Domain | CARD | 3.94e-03 | 33 | 53 | 2 | PS50209 | |
| Domain | GPS | 4.18e-03 | 34 | 53 | 2 | SM00303 | |
| Domain | GPS | 4.43e-03 | 35 | 53 | 2 | PF01825 | |
| Domain | UBA | 4.68e-03 | 36 | 53 | 2 | PF00627 | |
| Domain | GPS | 4.68e-03 | 36 | 53 | 2 | PS50221 | |
| Domain | TGFB | 4.94e-03 | 37 | 53 | 2 | SM00204 | |
| Domain | GPS | 4.94e-03 | 37 | 53 | 2 | IPR000203 | |
| Domain | TGF-b_C | 4.94e-03 | 37 | 53 | 2 | IPR001839 | |
| Domain | TGF_BETA_2 | 4.94e-03 | 37 | 53 | 2 | PS51362 | |
| Domain | TGF_beta | 4.94e-03 | 37 | 53 | 2 | PF00019 | |
| Domain | TGF_BETA_1 | 4.94e-03 | 37 | 53 | 2 | PS00250 | |
| Domain | SET | 6.04e-03 | 41 | 53 | 2 | PF00856 | |
| Domain | UBA | 6.93e-03 | 44 | 53 | 2 | IPR015940 | |
| Domain | SET | 7.55e-03 | 46 | 53 | 2 | SM00317 | |
| Domain | UBA | 7.87e-03 | 47 | 53 | 2 | PS50030 | |
| Domain | - | 8.74e-03 | 449 | 53 | 5 | 3.30.40.10 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.44e-06 | 188 | 43 | 7 | MM15828 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 1.20e-05 | 99 | 43 | 5 | MM14624 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.13e-04 | 158 | 43 | 5 | MM14812 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.95e-04 | 194 | 43 | 5 | M16312 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.26e-11 | 13 | 57 | 5 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.26e-11 | 13 | 57 | 5 | 1985902 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 10964771 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.26e-11 | 13 | 57 | 5 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.26e-11 | 13 | 57 | 5 | 16638824 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 20044046 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 32150576 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 22469976 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.26e-11 | 13 | 57 | 5 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.26e-11 | 13 | 57 | 5 | 28035001 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.26e-11 | 13 | 57 | 5 | 12832451 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.26e-11 | 13 | 57 | 5 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.26e-11 | 13 | 57 | 5 | 21670291 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.26e-11 | 13 | 57 | 5 | 23935487 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 2702644 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 8380065 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 1279194 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 15331748 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.26e-11 | 13 | 57 | 5 | 22406619 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 7628460 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 25724769 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.26e-11 | 13 | 57 | 5 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.26e-11 | 13 | 57 | 5 | 22092845 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 11801635 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 28913658 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 19008452 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.26e-11 | 13 | 57 | 5 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.26e-11 | 13 | 57 | 5 | 8500759 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.26e-11 | 13 | 57 | 5 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.26e-11 | 13 | 57 | 5 | 23800882 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 15207636 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 19285068 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 21760897 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.26e-11 | 13 | 57 | 5 | 1326665 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 21081647 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.26e-11 | 13 | 57 | 5 | 39168268 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 11483763 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 8402684 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 2164599 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 16619040 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.26e-11 | 13 | 57 | 5 | 8209741 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.26e-11 | 13 | 57 | 5 | 21949477 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 29396368 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 26219866 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 18003729 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 26284027 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 2133556 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 32521208 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.26e-11 | 13 | 57 | 5 | 33352461 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 19406938 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 38381498 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 20739537 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.26e-11 | 13 | 57 | 5 | 29967450 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.26e-11 | 13 | 57 | 5 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.26e-11 | 13 | 57 | 5 | 27695943 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 20404914 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 16680193 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 26911181 | ||
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 1653760 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.26e-11 | 13 | 57 | 5 | 32027621 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.26e-11 | 13 | 57 | 5 | 27777319 | |
| Pubmed | 1.26e-11 | 13 | 57 | 5 | 18848945 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 37531413 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 23780386 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 28567513 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 8207827 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.96e-11 | 14 | 57 | 5 | 34666041 | |
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 19700760 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 34619794 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 1.96e-11 | 14 | 57 | 5 | 25498293 | |
| Pubmed | Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. | 1.96e-11 | 14 | 57 | 5 | 29746166 | |
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 9212243 | ||
| Pubmed | CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. | 1.96e-11 | 14 | 57 | 5 | 27572314 | |
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 1648219 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 1.96e-11 | 14 | 57 | 5 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 1.96e-11 | 14 | 57 | 5 | 32209360 | |
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 11994468 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 11850617 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 1.96e-11 | 14 | 57 | 5 | 27161904 | |
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 1.96e-11 | 14 | 57 | 5 | 26196244 | |
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 8896983 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 22962327 | ||
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 17623671 | ||
| Interaction | PSG4 interactions | 3.71e-09 | 8 | 56 | 4 | int:PSG4 | |
| Interaction | PSG1 interactions | 2.94e-07 | 51 | 56 | 5 | int:PSG1 | |
| Interaction | NLGN3 interactions | 8.09e-06 | 99 | 56 | 5 | int:NLGN3 | |
| Interaction | PSG3 interactions | 3.01e-05 | 22 | 56 | 3 | int:PSG3 | |
| Interaction | PLEKHG7 interactions | 6.01e-05 | 150 | 56 | 5 | int:PLEKHG7 | |
| Interaction | PSG5 interactions | 7.54e-05 | 5 | 56 | 2 | int:PSG5 | |
| Cytoband | 19q13.2 | 5.92e-08 | 164 | 57 | 6 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.08e-04 | 1192 | 57 | 8 | chr19q13 | |
| Cytoband | 9q34.3 | 3.20e-04 | 106 | 57 | 3 | 9q34.3 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.24e-11 | 11 | 37 | 5 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.93e-05 | 163 | 37 | 5 | 590 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 1.71e-03 | 30 | 37 | 2 | 959 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.32e-03 | 394 | 37 | 4 | 471 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 7.14e-09 | 32 | 56 | 5 | MM2 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.07e-08 | 128 | 56 | 7 | MM1000 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.15e-08 | 35 | 56 | 5 | MM757 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 4.77e-08 | 93 | 56 | 6 | M40279 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 5.92e-08 | 48 | 56 | 5 | MM531 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 4.39e-07 | 135 | 56 | 6 | MM965 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 4.93e-07 | 224 | 56 | 7 | M40145 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 5.71e-07 | 75 | 56 | 5 | MM605 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 1.20e-06 | 87 | 56 | 5 | MM851 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 2.51e-06 | 182 | 56 | 6 | MM993 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 4.45e-06 | 201 | 56 | 6 | MM1294 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 9.63e-06 | 230 | 56 | 6 | MM986 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 1.38e-05 | 143 | 56 | 5 | MM989 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 2.29e-05 | 159 | 56 | 5 | MM760 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 3.16e-05 | 284 | 56 | 6 | MM987 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 3.25e-05 | 171 | 56 | 5 | M40134 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 6.80e-05 | 102 | 56 | 4 | M10290 | |
| Coexpression | GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP | 6.85e-05 | 200 | 56 | 5 | M3425 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 7.02e-05 | 201 | 56 | 5 | MM1006 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 8.03e-05 | 490 | 56 | 7 | MM1001 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 1.05e-04 | 219 | 56 | 5 | MM3826 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 2.00e-04 | 568 | 56 | 7 | MM3824 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 3.29e-04 | 436 | 56 | 6 | MM1326 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.47e-07 | 191 | 56 | 6 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.03e-06 | 101 | 56 | 4 | cf52c93f523c5f25bd45519a1444ce7bd1d8b577 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.86e-05 | 125 | 56 | 4 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-05 | 133 | 56 | 4 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | Striatum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.38e-05 | 133 | 56 | 4 | d5326a6ccada5ae6d3e8f7d4a858c90050e23c5b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crhr2_Efemp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.60e-05 | 136 | 56 | 4 | e3a2425ba5ef538dbacab1479e682837ae42a888 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.60e-05 | 136 | 56 | 4 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.25e-05 | 144 | 56 | 4 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.52e-05 | 147 | 56 | 4 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.71e-05 | 149 | 56 | 4 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.02e-05 | 161 | 56 | 4 | dccb61d5e17a8f1c6d1fc146ee389f567659a0f0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.20e-05 | 170 | 56 | 4 | 8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.78e-05 | 174 | 56 | 4 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|COVID-19_Convalescent / Disease condition and Cell class | 7.57e-05 | 179 | 56 | 4 | 366e4a31db9e80fd1770ac9f1ae148fefeb9f7df | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 7.57e-05 | 179 | 56 | 4 | 9d51318ac198a8801bd5c7031ebf2b0c74ffeeb6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_KLHL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.25e-05 | 183 | 56 | 4 | 439b1d1373b7cc73d65f3b59037a6def7cf8f4ba | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.42e-05 | 184 | 56 | 4 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 184 | 56 | 4 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.42e-05 | 184 | 56 | 4 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 184 | 56 | 4 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 184 | 56 | 4 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.42e-05 | 184 | 56 | 4 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 185 | 56 | 4 | e502ec54971f518d0cf1b619b745607a8ab5ddf3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.96e-05 | 187 | 56 | 4 | 85f1678338a47d91e296f0620d4887f057eb7e70 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.96e-05 | 187 | 56 | 4 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 8.96e-05 | 187 | 56 | 4 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.15e-05 | 188 | 56 | 4 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.15e-05 | 188 | 56 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.15e-05 | 188 | 56 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.34e-05 | 189 | 56 | 4 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.34e-05 | 189 | 56 | 4 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.34e-05 | 189 | 56 | 4 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 9.53e-05 | 190 | 56 | 4 | 58a6ab70737d719ca9725ac087f20dfe9be0463e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.73e-05 | 191 | 56 | 4 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 9.73e-05 | 191 | 56 | 4 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.73e-05 | 191 | 56 | 4 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 9.92e-05 | 192 | 56 | 4 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.92e-05 | 192 | 56 | 4 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-05 | 192 | 56 | 4 | 967122c53af25b8f19a8411b4553d764c8d51c4d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | 8b77625bf3c87d39767fb391d1beaca4ab02342b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | 2c15186d15545804cc262da9137ab825609d4b2c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 193 | 56 | 4 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 193 | 56 | 4 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-04 | 193 | 56 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.01e-04 | 193 | 56 | 4 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 194 | 56 | 4 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-04 | 194 | 56 | 4 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 195 | 56 | 4 | 3f517c6fc372bdcaf45b3af373414f13cbebd4ba | |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.10e-04 | 197 | 56 | 4 | e8861abffbb7169f1923fad6e565865eee22f310 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-04 | 197 | 56 | 4 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Dendritic_cell / Region, Cell class and subclass | 1.10e-04 | 197 | 56 | 4 | 8545baf923ddf84c5ce9414a36d810603be52401 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-04 | 198 | 56 | 4 | 3c23fb8a84d4e4a20f7fa60055c7b37fc45a29d5 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.12e-04 | 198 | 56 | 4 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 198 | 56 | 4 | 72d86b6edc85ba7dfe7daf39f1201771c2b482d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.12e-04 | 198 | 56 | 4 | 5fc25b008a4d8d6bec83923a16f64dd9e1ff1f2d | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-04 | 198 | 56 | 4 | 9ce9b3721fb8a154667211c29e60133412134c76 | |
| ToppCell | distal-1-Epithelial-Club|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | 8f0a72a95d0310ef2324c6975495c294b5a47cc8 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | 121de4e02585de3a3010398387c523bacf8ce546 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-gdT|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.14e-04 | 199 | 56 | 4 | a0f1e0d1aa175c2dcc5e744fff8b56ddda5293df | |
| ToppCell | distal-Epithelial-Club-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.14e-04 | 199 | 56 | 4 | 685cefbe6ff5db8b578e50b5849524ac2f347d0c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 858421b91f5207b7934b5c219752cb9322a3da31 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 8d51b4f7b7002ee51401ebe5eaca1e8f04bfadd5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 1ec2f322f936d2501330c53bb7c9390216c50cd1 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 05bcde6ce8f1354ef65e4eb9cbd963a92108081c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 6a44439e4a7ce3627271375b04cfcfb9467218f4 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD--L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | e250b2e45ef869f81cc40cc41f53d1e54e7848aa | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-STK32A--L4-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | cb1f4b0d66da5b0466ff17b29e7034d451d93e4f | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 1a04331862079092bc04b1010aa9228c0fa3d8c5 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | a7022762c1d8aedb7b3e9605873b1e68b9907b35 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.16e-04 | 200 | 56 | 4 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-KLHDC8A--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | fb56d430957e73fba17db7bc0127ecf3577e0867 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-HPGD|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | dea96adbd9a77fe50ff397d4bdeb4dc8f50de3b7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.16e-04 | 200 | 56 | 4 | 2131c8e7fa054b79906eaf60536da892438b09cd | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.48e-04 | 97 | 56 | 3 | f3c3fb260954f594a9ab8e1ac9a01115767cbc7a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.31e-04 | 107 | 56 | 3 | fc07dd90f280191bd643398eac5c8273651d0925 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.09e-04 | 115 | 56 | 3 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.74e-04 | 121 | 56 | 3 | 056d0f0f7a4d1b2d38b83647bbe4468b7c959ce6 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.86e-04 | 122 | 56 | 3 | eae9d94f8510ac0f434942451d55c7260977b178 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.33e-04 | 126 | 56 | 3 | 84dce108561d4b745d19250c2ac0667d9e4ea17d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.33e-04 | 126 | 56 | 3 | 94bd9cfe982b41a3114885173eab55feb0fbbbae | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.46e-04 | 127 | 56 | 3 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.71e-04 | 129 | 56 | 3 | f83187c0bb06528127b8d2d56674ab1946846951 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.71e-04 | 129 | 56 | 3 | 6bc85761dea1f97c19bb379a99e4daf85d53201e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Esm1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.97e-04 | 131 | 56 | 3 | 3cb4b272e28ee9bad6d874f64a7aae18352a6cfb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.24e-04 | 133 | 56 | 3 | fc319644868078ea0f88a71d55f5e858c6848b50 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|GI_small-bowel / Manually curated celltypes from each tissue | 6.52e-04 | 135 | 56 | 3 | 11a672ab6cba7026b8d81d8b216443cb88c0d47a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-04 | 138 | 56 | 3 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-04 | 138 | 56 | 3 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.10e-04 | 139 | 56 | 3 | c9bf98bed77415a1438f3f9e441a1346e75c26b0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Crh_4930553C11Rik_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.40e-04 | 141 | 56 | 3 | ad9a25569c142fb68ded34aeba0cd9be8124ce56 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.70e-04 | 143 | 56 | 3 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | COVID-19_Severe-MAIT|World / disease group, cell group and cell class | 8.02e-04 | 145 | 56 | 3 | 8d63f97812f63329ef9c940b291dc5a1c4d90690 | |
| ToppCell | Healthy-CD4+_T_activated|Healthy / disease group, cell group and cell class | 8.02e-04 | 145 | 56 | 3 | 45e8089fdf7d6f69b383816d8945e39fba24c873 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 148 | 56 | 3 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Etv1_|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.51e-04 | 148 | 56 | 3 | 4d43efee96a6493abd78e9ca41aab73db0c80626 | |
| Computational | Neighborhood of CDKN1C | 1.53e-08 | 27 | 33 | 5 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 3.77e-08 | 32 | 33 | 5 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 6.04e-08 | 35 | 33 | 5 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.56e-07 | 42 | 33 | 5 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.49e-07 | 46 | 33 | 5 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 3.44e-07 | 49 | 33 | 5 | GNF2_KISS1 | |
| Drug | AC1L1IPV | 6.72e-08 | 43 | 56 | 5 | CID000004683 | |
| Disease | cD177 antigen measurement | 3.24e-08 | 18 | 55 | 4 | EFO_0021866 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 3 in blood serum | 3.41e-06 | 2 | 55 | 2 | OBA_2043058 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 4 in blood serum | 3.41e-06 | 2 | 55 | 2 | OBA_2043059 | |
| Disease | level of N-sulphoglucosamine sulphohydrolase in blood serum | 3.40e-05 | 5 | 55 | 2 | OBA_2043486 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 5.09e-05 | 6 | 55 | 2 | EFO_0801907 | |
| Disease | CONOTRUNCAL HEART MALFORMATIONS (disorder) | 5.09e-05 | 6 | 55 | 2 | C1857586 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 7.12e-05 | 7 | 55 | 2 | EFO_0801906 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.06e-04 | 49 | 55 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.66e-04 | 181 | 55 | 4 | DOID:684 (is_implicated_in) | |
| Disease | Tetralogy of Fallot | 4.03e-04 | 16 | 55 | 2 | C0039685 | |
| Disease | refractive error, age at onset, Myopia | 4.66e-04 | 193 | 55 | 4 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | intellectual disability (is_implicated_in) | 1.44e-03 | 30 | 55 | 2 | DOID:1059 (is_implicated_in) | |
| Disease | colorectal cancer (is_implicated_in) | 1.51e-03 | 121 | 55 | 3 | DOID:9256 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EPILIPRVRRAVLPQ | 196 | P02760 | |
| QRREGLPRPLPLLVQ | 176 | Q8NHY0 | |
| PIRVSEPVLSLPVRR | 236 | Q6P6C2 | |
| LPRPLERPVLVEFAL | 2386 | Q9NYQ6 | |
| KPPRPLEGRIARLIQ | 326 | Q8N865 | |
| RILELTPEPDRPRIL | 1241 | Q14004 | |
| QVLPDVRLLPRRLPL | 21 | Q9Y463 | |
| RAVPVKRPRVTVPLV | 141 | Q9UKM9 | |
| HPLTPRRVAVPVLVR | 201 | A6NCS4 | |
| IPHPRRLSPVVIRRI | 31 | Q96T59 | |
| LVRPIRAVCRILQIP | 11 | P0DUH7 | |
| RQAPPLIRQAPPVIR | 431 | Q9UJ55 | |
| RQAPPVIRQAPPVIR | 466 | Q9UJ55 | |
| VVRVDLRRLAPAPPA | 401 | Q86Y97 | |
| VLLRQLVPALGPPVR | 181 | P27539 | |
| PVPPRLDLIQKGIVR | 506 | Q13191 | |
| PENLLIDLRIPVPRV | 2806 | O60229 | |
| IPVIAVLTRRLPPIK | 771 | P42356 | |
| VPAPAVRILTPEVRL | 81 | Q99988 | |
| PRPPLKERRVQRIQE | 156 | Q7L590 | |
| LPKVPERIRRRIQPS | 346 | Q9Y5Y3 | |
| RQLRTFVLPVTPPRL | 211 | P32942 | |
| RIHQDIPLPPRRREL | 1041 | Q8TCU5 | |
| ARRLDPTEPIRTPII | 266 | Q96FL9 | |
| LEQLRRLPLPPPQIR | 21 | A6NGQ2 | |
| RPRPVLLVPRAVGKI | 826 | Q9BXL6 | |
| EAVLPRLRVTRPLVP | 66 | Q6ZV77 | |
| RLRVTRPLVPEPAIL | 71 | Q6ZV77 | |
| LTPVVLRPEIRKPEV | 106 | P55211 | |
| KILALRQARRPVPPE | 861 | Q6P1N0 | |
| LREFIERRPVIPPSI | 6 | Q5SVJ3 | |
| RRLSIIPPVIQPEII | 311 | Q9ULL0 | |
| IPPETLRKRNFRIPL | 7036 | Q8NDH2 | |
| IPVRIPVSRPVLTLR | 291 | Q96LA5 | |
| LPATIARIPPVAVRL | 1871 | Q14839 | |
| PVSPRVKRPIENRIL | 281 | Q00888 | |
| LRRRAVVKEPLLPPE | 731 | P12830 | |
| PVSPRVKRPIENRIL | 281 | P11464 | |
| VSRPRLVLPRLALPV | 2211 | P98161 | |
| VRLVIGRVLELPRIP | 1861 | Q12923 | |
| PVSPRVKRPIENRIL | 281 | Q16557 | |
| VIPPIRSRCLAVRVP | 171 | P40938 | |
| RQLKRPRPVILDPAD | 286 | Q9Y6K5 | |
| VRLPVNVLVPSRPPR | 261 | Q75VX8 | |
| LNRLLLVPCPPLRRV | 96 | Q9BVQ7 | |
| LTVRVIEARDLPPPI | 201 | Q9BSW7 | |
| DLQEPRPRAKRRPIV | 96 | P58417 | |
| PVSPRVKRPIENRIL | 281 | Q9UQ74 | |
| RRLLQPEHPREVLVP | 476 | O75626 | |
| RPRDLPAIQPRLVAV | 31 | O94903 | |
| EPVQPLLREVLRPSR | 66 | Q96CW6 | |
| PRTVLERKPLPLGVR | 131 | Q86UD0 | |
| RNSVCIIPLRRVPVP | 456 | O43818 | |
| PAPDNVLLTLRPRRI | 216 | Q9NXZ1 | |
| LALEILPERVPTPRI | 96 | Q56A73 | |
| RPPLKQVSERRLRPL | 321 | Q8WWL2 | |
| PPTIVLDLQVRRVRP | 316 | Q9NVW2 | |
| PRIPRELLQHVRQPV | 486 | Q5T7W7 | |
| RRPEPIIPVTQPRLA | 521 | Q92797 | |
| LEVVRERKALPPRLP | 806 | Q5SXM2 | |
| PRVKRPIENRILILP | 191 | Q15238 | |
| ANRRPLPELVRAKIP | 526 | Q92995 |